Sunny Singh
Assistant Professor
Also affiliated: Saint Barnabas Medical Center (2020); Ministry of Industry and Trade (2023); University of British Columbia (2022–2024); Henry Ford Health System (2019–2023); Institute of Management Technology (2024); University of Calgary (2015); PES University (2022); Indira Gandhi Institute of Medical Sciences (2025); John H. Stroger, Jr. Hospital of Cook County (2016–2019); Kelowna General Hospital (2024); Henry Ford Hospital (2019–2023); King George's Medical University (2013–2014); St. Peter's Institute of Higher Education and Research (2024–2025); University of California San Diego (2024); Birla Institute of Technology and Science - Hyderabad Campus (2023); The Wright Center for Graduate Medical Education (2020); Amity University (2016); Cook County Health and Hospitals System (2020); University of British Columbia, Okanagan Campus (2024); University of Manitoba (2009–2011); Tumkur University (2023); Indian Institute of Technology BHU (2022–2023); Chitkara University (2014–2023); Bharati Vidyapeeth Deemed University (2024–2025); Maulana Azad National Institute of Technology (2019); Banaras Hindu University (2021–2023); Dehradun Institute of Technology University (2023)
Faculty Researcher
COM | Internal Med Hem-Onc
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Sunny Singh's research program focuses on investigating health disparities and outcomes, particularly within the context of cancer and infectious diseases. He has published work examining racial disparities in COVID-19 outcomes among Black and White patients with cancer, as well as breakthrough SARS-CoV-2 infections in cancer patients following mRNA vaccination. Singh's research also includes analyses of epidemiological data for melanoma, assessing outcomes by subtype and sociodemographic factors.
Beyond direct clinical outcomes, Singh's work has explored the application of artificial intelligence and machine learning in medical diagnostics, including an AI model for tuberculosis diagnosis. His publication record also includes broader studies on wireless body area networks and financial trend analysis using machine learning.
Singh is an Assistant Professor in Internal Medicine, Hematology-Oncology at the University of Arkansas for Medical Sciences. His scholarly metrics include an h-index of 17, with over 155 publications and nearly 2,000 citations. He leads a research group and collaborates with several colleagues at his institution, including Sindhu Janarthanam Malapati, Shi‐Ming Tu, Timothy Langford, and Neriman Gökden.
Metrics
- h-index: 17
- Publications: 155
- Citations: 2,003
Selected Publications
-
Real-world analysis of CRS and ICANS following tarlatamab and its association with survival in patients with SCLC. (2026)
-
COVID-19 in Patients With Gynecologic Cancer: A Report From the COVID-19 and Cancer Consortium (2026)
-
Stem Cell Origin of Cancer: Biological Principles and Clinical Strategies for Chemoprevention and Maintenance Therapy in Cancer Care (2025)
-
Navigating Hyperhemolysis in Sickle Cell Disease: Insights from Literature (2025)
-
Obesity’s Disparate Impact on COVID-19 Outcomes in Asian American Patients with Cancer (2025)
-
Associations of COVID-19 vaccination with risks for post-infectious cardiovascular complications: an international cohort study in cancer patients with SARS-CoV-2 infection (2025)
-
Stem Cell Origin of Cancer: Clinical Implications beyond Immunotherapy for Drug versus Therapy Development in Cancer Care (2024)
-
The impact of cancer metastases on COVID‐19 outcomes: A COVID‐19 and Cancer Consortium registry‐based retrospective cohort study (2024)
-
Stem Cell Theory of Cancer: Clinical Implications for Cellular Metabolism and Anti-Cancer Metabolomics (2024)
-
Stem Cell Theory of Cancer: Clinical Implications of Epigenomic versus Genomic Biomarkers in Cancer Care (2023)
-
Stem Cell Origin of Cancer: Clinical Implications for Cancer Immunity and Immunotherapy (2023)
-
Parent Penalty: Parental Leave Experiences of Trainees and Early-Career Faculty in Oncology Subspecialties (2023)
-
Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19 (2023)
-
A Comprehensive Review on the Role of Human Epidermal Growth Factor Receptor 2 (HER2) as a Biomarker in Extra-Mammary and Extra-Gastric Cancers (2023)
-
Stem Cell Origin of Cancer: Implications of Oncogenesis Recapitulating Embryogenesis in Cancer Care (2023)
Collaboration Network
Top Collaborators
- A Comprehensive Review on the Role of Human Epidermal Growth Factor Receptor 2 (HER2) as a Biomarker in Extra-Mammary and Extra-Gastric Cancers
- Stem Cell Theory of Cancer: Implications for Translational Research from Bedside to Bench
- Where is your lactation room? Lactation policies and practices in oncology trainee and early career physicians.
- Parent Penalty: Parental Leave Experiences of Trainees and Early-Career Faculty in Oncology Subspecialties
- Stem Cell Origin of Cancer: Clinical Implications beyond Immunotherapy for Drug versus Therapy Development in Cancer Care
Showing 5 of 6 shared publications
- Stem Cell Theory of Cancer: Implications for Translational Research from Bedside to Bench
- Stem Cell Origin of Cancer: Implications of Oncogenesis Recapitulating Embryogenesis in Cancer Care
- Stem Cell Theory of Cancer: Clinical Implications for Cellular Metabolism and Anti-Cancer Metabolomics
- Stem Cell Theory of Cancer: Clinical Implications of Epigenomic versus Genomic Biomarkers in Cancer Care
- Stem Cell Origin of Cancer: Biological Principles and Clinical Strategies for Chemoprevention and Maintenance Therapy in Cancer Care
- Stem Cell Origin of Cancer: Implications of Oncogenesis Recapitulating Embryogenesis in Cancer Care
- Stem Cell Theory of Cancer: Clinical Implications for Cellular Metabolism and Anti-Cancer Metabolomics
- Stem Cell Origin of Cancer: Clinical Implications for Cancer Immunity and Immunotherapy
- Stem Cell Theory of Cancer: Clinical Implications of Epigenomic versus Genomic Biomarkers in Cancer Care
- Stem Cell Origin of Cancer: Implications of Oncogenesis Recapitulating Embryogenesis in Cancer Care
- Stem Cell Theory of Cancer: Clinical Implications for Cellular Metabolism and Anti-Cancer Metabolomics
- Stem Cell Origin of Cancer: Clinical Implications for Cancer Immunity and Immunotherapy
- Stem Cell Theory of Cancer: Clinical Implications of Epigenomic versus Genomic Biomarkers in Cancer Care
- Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19
- The impact of cancer metastases on COVID‐19 outcomes: A COVID‐19 and Cancer Consortium registry‐based retrospective cohort study
- Associations of COVID-19 vaccination with risks for post-infectious cardiovascular complications: an international cohort study in cancer patients with SARS-CoV-2 infection
- COVID-19 in Patients With Gynecologic Cancer: A Report From the COVID-19 and Cancer Consortium
- Where is your lactation room? Lactation policies and practices in oncology trainee and early career physicians.
- Parent Penalty: Parental Leave Experiences of Trainees and Early-Career Faculty in Oncology Subspecialties
- The parent penalty: Parental leave and return to work in trainees and early-career faculty in oncology.
- Where is your lactation room? Lactation policies and practices in oncology trainee and early career physicians.
- Parent Penalty: Parental Leave Experiences of Trainees and Early-Career Faculty in Oncology Subspecialties
- The parent penalty: Parental leave and return to work in trainees and early-career faculty in oncology.
- Where is your lactation room? Lactation policies and practices in oncology trainee and early career physicians.
- Parent Penalty: Parental Leave Experiences of Trainees and Early-Career Faculty in Oncology Subspecialties
- The parent penalty: Parental leave and return to work in trainees and early-career faculty in oncology.
- Where is your lactation room? Lactation policies and practices in oncology trainee and early career physicians.
- Parent Penalty: Parental Leave Experiences of Trainees and Early-Career Faculty in Oncology Subspecialties
- The parent penalty: Parental leave and return to work in trainees and early-career faculty in oncology.
- Where is your lactation room? Lactation policies and practices in oncology trainee and early career physicians.
- Parent Penalty: Parental Leave Experiences of Trainees and Early-Career Faculty in Oncology Subspecialties
- The parent penalty: Parental leave and return to work in trainees and early-career faculty in oncology.
- Stem Cell Theory of Cancer: Implications for Translational Research from Bedside to Bench
- Stem Cell Origin of Cancer: Clinical Implications beyond Immunotherapy for Drug versus Therapy Development in Cancer Care
- Real-world analysis of CRS and ICANS following tarlatamab and its association with survival in patients with SCLC.
- Stem Cell Origin of Cancer: Implications of Oncogenesis Recapitulating Embryogenesis in Cancer Care
- Stem Cell Origin of Cancer: Clinical Implications for Cancer Immunity and Immunotherapy
- Stem Cell Theory of Cancer: Clinical Implications of Epigenomic versus Genomic Biomarkers in Cancer Care
- Stem Cell Origin of Cancer: Implications of Oncogenesis Recapitulating Embryogenesis in Cancer Care
- Stem Cell Theory of Cancer: Clinical Implications for Cellular Metabolism and Anti-Cancer Metabolomics
- Stem Cell Origin of Cancer: Clinical Implications for Cancer Immunity and Immunotherapy
- Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19
- The impact of cancer metastases on COVID‐19 outcomes: A COVID‐19 and Cancer Consortium registry‐based retrospective cohort study
- Associations of COVID-19 vaccination with risks for post-infectious cardiovascular complications: an international cohort study in cancer patients with SARS-CoV-2 infection
- Navigating Hyperhemolysis in Sickle Cell Disease: Insights from Literature
- Navigating Hyperhemolysis in Sickle Cell Disease: Insights from Literature
- Stem Cell Origin of Cancer: Clinical Implications beyond Immunotherapy for Drug versus Therapy Development in Cancer Care
Similar Researchers
Based on overlapping research topics